Detailed Characterization and Comparison of Mouse Models for Cholangiocarcinoma

Area of Science:

• Oncology
• Gastroenterology
• Translational Research

Background:

• Cholangiocarcinoma (CCA) is an aggressive bile duct cancer with late diagnosis and limited treatments.
• CCA represents 10-15% of primary liver tumors, with recent research focusing on genetic mutations for targeted therapies.
• Existing mouse models for CCA need thorough investigation to ensure they accurately reflect human disease complexity.

Purpose of the Study:

• To characterize and compare available mouse models for cholangiocarcinoma (CCA) research.
• To evaluate the resemblance of mouse CCA models to human CCA characteristics, including tumor subtypes and microenvironment.
• To assess the suitability of different mouse models for studying CCA.

Main Methods:

• Utilized tissue-based techniques: hematoxylin and eosin, Sirius red, and immunohistochemistry for 16 markers.
• Analyzed tumor cells and the tumor microenvironment in 11 distinct mouse models.
• Compared morphologic subtypes, growth patterns, and microenvironment activity across models.

Main Results:

• CCA mouse models exhibit diverse tumor subtypes, growth patterns, and microenvironment activity.
• Significant differences in non-CCA neoplastic lesions (e.g., hepatocellular carcinoma) and nonneoplastic changes were observed.
• Nine out of 11 mouse models demonstrated suitability for CCA studies due to resemblance to human CCA features.

Conclusions:

• Mouse models of CCA are valuable tools for investigating this deadly malignancy.
• The suitability of CCA mouse models varies, necessitating careful selection based on specific research objectives.
• Further characterization confirms the utility of select mouse models in advancing CCA research and therapeutic development.